Definitions & Neurobiology - Brain's Tricky Treat
- Substance Use Disorder: Problematic pattern of substance use leading to clinically significant impairment or distress (DSM-5/ICD-11 classification replacing "drug abuse" and "dependence").
- Psychological: Craving, emotional reliance.
- Physical: Bodily adaptation; withdrawal on stopping.
- Tolerance: ↓ drug effect; ↑ dose for same effect. Types: metabolic, cellular.
- Withdrawal: Symptoms on drug cessation/reduction.
- Addiction: Chronic, relapsing disorder; compulsive drug use.
- Neurobiological Pathways: Complex interplay involving mesolimbic pathway (VTA → NAc → PFC), extended amygdala (stress/negative states), prefrontal cortex (executive function), and glutamatergic systems (learning/memory). Dopamine (DA) release reinforces drug use.

⭐ Psychological dependence: craving (Dopamine in Nucleus Accumbens). Physical dependence: neuroadaptation (e.g., altered receptors), causing withdrawal.
Drug Classes & Effects - Popular Poisons Parade
| Class | E.g. | MoA | Intoxication Sx | Withdrawal Sx |
|---|---|---|---|---|
| Opioids | Heroin, Morphine | Mu-agonist | 📌CRUSH (Coma, Resp↓, Pinpoint pupils), SBP↓ | Flu-like, mydriasis, piloerection |
| CNS Depressants | Barbs, BZDs | GABA$_A$ ↑ | Drowsiness, ataxia, slurred speech, resp↓ | Anxiety, seizures (life-threatening) |
| CNS Stimulants | Cocaine, Amphs | ↑DA/NE/5-HT | Agitation, HTN, ↑HR, mydriasis; Psychosis (Amph), Formication (Cocaine) | "Crash": dysphoria, fatigue |
| Hallucinogens | LSD, PCP | LSD: 5-HT$_{2A}$ ↑; PCP: NMDA↓ | LSD: Perceptual Δs; PCP: aggression, nystagmus | LSD: Flashbacks. PCP: Anxiety. |
| Cannabis | THC | CB1/CB2 agonist | Euphoria, ↑appetite, red eyes, impaired coordination | Irritability, anxiety, insomnia |
| Inhalants | Solvents, Nitrites | CNS depressant | Euphoria, dizziness, slurred speech; "sudden sniffing death" | Mild; irritability, nausea |
💡 Clinical Pearl: Under BNS Sec 328, voluntary consumption of narcotic drugs is distinguished from involuntary poisoning through BNSS Sec 176 procedures requiring comprehensive toxicological examination and BSA-compliant evidence documentation using DSM-5-TR criteria and transitioning ICD-11 classification standards.
Toxidromes & Management - Antidote Avengers
| Toxidrome | Signs (Pupils, Skin, Vitals) | Drugs | Antidote & Dose(s) |
|---|---|---|---|
| Opioid | Pinpoint pupils, ↓RR, altered mental status | Heroin | Naloxone 0.4-2mg IV (titrate based on response). |
| Sympathomimetic | Mydriasis, ↑HR/BP/Temp, sweat, agitation | Cocaine | BZDs (Diazepam 5-10mg IV). |
| Sedative-Hypnotic | Variable pupils, ↓RR, somnolence/coma | BZDs, Barbs | Flumazenil 0.2mg IV (BZD). Supportive. |
| Cholinergic | Miosis, SLUDGE, bradycardia, bronchorrhea | OPs, Carbamates | Atropine 2-5mg IV. Pralidoxime 500mg IV + 10mg/kg/hr infusion. |
| Anticholinergic | Mydriasis, dry/hot skin, ↑Temp, delirium | Atropine, TCAs | Physostigmine 0.5-2mg IV. 📌 "Blind as a bat..." |
| Paracetamol | Hepatotoxicity | Paracetamol | NAC 150mg/kg IV load. |
| Methanol/EG | AGMA, visual/renal | Methanol, EG | Fomepizole 15mg/kg IV load / Ethanol. |
| %%{init: {'flowchart': {'htmlLabels': true}}}%% | |||
| flowchart TD |
A["⚠️ Suspected Overdose
• Patient intake• Acute poisoning"]
B["📋 Clinical Assessment
• Monitor vitals• Physical exam"]
C["🩺 Toxidrome Identification
• Recognize signs• Define syndrome"]
D["⚖️ BNS Sec 284
• Poisoning cases• Legal compliance"]
E["🔬 BNSS Sec 174
• Medical exam• Forensic check"]
F["🧪 BSA Evidence
• Collection step• Sample custody"]
G["💊 Antidote Admin
• Give treatment• Patient recovery"]
A --> B B --> C C --> D D --> E E --> F F --> G
style A fill:#FDF4F3, stroke:#FCE6E4, stroke-width:1.5px, rx:12, ry:12, color:#B91C1C style B fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E style C fill:#F7F5FD, stroke:#F0EDFA, stroke-width:1.5px, rx:12, ry:12, color:#6B21A8 style D fill:#F6F5F5, stroke:#E7E6E6, stroke-width:1.5px, rx:12, ry:12, color:#525252 style E fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C style F fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C style G fill:#F1FCF5, stroke:#BEF4D8, stroke-width:1.5px, rx:12, ry:12, color:#166534
> ⭐ Flumazenil: risk of seizures in chronic BZD users or TCA overdose.
## Forensic Toxicology & Law - Law & Lab Logic
* **NDPS Act, 1985**: Governs drugs with significant amendments including the Narcotic Drugs and Psychotropic Substances (Amendment) Bill, 2021. Defines: Cannabis, Opium, Psychotropics. **Small vs. Commercial quantity** distinctions refined with evolving penalties for possession/trafficking.
* **Medico-legal Samples**: Blood (**2-10ml** + NaF for alcohol), Urine (**30-50ml** based on analysis type), Vitreous, Hair, Saliva. Volume requirements vary by suspected substance and laboratory protocols. Label meticulously.
* **Chain of Custody**: Unbroken record of sample handling under **BSA** evidence requirements. Ensures integrity, legal admissibility.
* **Drug Testing**: Screening (Immunoassays - presumptive, potential cross-reactivity) vs. **Mandatory** Confirmatory (GC-MS, LC-MS, HRMS - definitive). Both steps essential for robust analysis.
```mermaid
%%{init: {'flowchart': {'htmlLabels': true}}}%%
flowchart TD
Start["<b>🧪 Sample Intake</b><br><span style='display:block; text-align:left; color:#555'>• Collect drug sample</span><span style='display:block; text-align:left; color:#555'>• Forensic handling</span>"]
Chain["<b>📋 Evidence Chain</b><br><span style='display:block; text-align:left; color:#555'>• BSA tracking</span><span style='display:block; text-align:left; color:#555'>• Maintain custody</span>"]
Screen["<b>🔬 Screening Test</b><br><span style='display:block; text-align:left; color:#555'>• Initial immunoassay</span><span style='display:block; text-align:left; color:#555'>• Rapid detection</span>"]
Confirm["<b>🔬 Gold Standard</b><br><span style='display:block; text-align:left; color:#555'>• GC-MS/LC-MS check</span><span style='display:block; text-align:left; color:#555'>• Confirm results</span>"]
Legal["<b>⚖️ Compliance</b><br><span style='display:block; text-align:left; color:#555'>• NDPS Act 2024</span><span style='display:block; text-align:left; color:#555'>• Legal standards</span>"]
Start --> Chain
Chain --> Screen
Screen --> Confirm
Confirm --> Legal
style Start fill:#EEFAFF, stroke:#DAF3FF, stroke-width:1.5px, rx:12, ry:12, color:#0369A1
style Chain fill:#FEF8EC, stroke:#FBECCA, stroke-width:1.5px, rx:12, ry:12, color:#854D0E
style Screen fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C
style Confirm fill:#FFF7ED, stroke:#FFEED5, stroke-width:1.5px, rx:12, ry:12, color:#C2410C
style Legal fill:#F6F5F5, stroke:#E7E6E6, stroke-width:1.5px, rx:12, ry:12, color:#525252
⭐ Detecting a drug metabolite (e.g., benzoylecgonine for cocaine) in urine, not just the parent drug, strongly indicates recent drug administration and metabolism by the body.
High‑Yield Points - ⚡ Biggest Takeaways
- Drug abuse is non-medical use; dependence includes tolerance and withdrawal symptoms.
- Opioids (heroin): pinpoint pupils, respiratory depression. Antidote: Naloxone.
- Cocaine: mydriasis, tachycardia, seizures. Crack cocaine is highly potent.
- Cannabis (THC): conjunctival congestion, impaired coordination, dry mouth.
- Amphetamines: CNS stimulants causing psychosis, hyperthermia, cardiac issues.
- Barbiturates: CNS depressants, respiratory failure, no specific antidote.
- Benzodiazepines: Safer CNS depressants. Antidote: Flumazenil.